MicroRNAs Regulate Bone Development and Regeneration

Fang, Sijie; Deng, Yuan; Gu, Ping; Fan, Xianqun

doi:10.3390/ijms16048227

Cited by 95 publications

(71 citation statements)

References 128 publications

(200 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Human quality of life may be seriously affected by bone defects caused by congenital malformations, traumas or diseases, imposing large economic and social burdens [8]. To treat or prevent these diseases, the key issue is promoting osteogenesis.…”

Section: Introductionmentioning

confidence: 99%

MicroRNA-223 Suppresses Osteoblast Differentiation by Inhibiting DHRS3

Zhang

Liu

Zheng

et al. 2018

Cell Physiol Biochem

View full text Add to dashboard Cite

Background/Aims: In this study, we aimed to use bioinformatics tools to identify the specific miRNAs and mRNAs involved in osteogenic differentiation and to further explore the way in which miRNA regulates osteogenic differentiation. Methods: The microarray GSE80614, which includes data from 3 human mesenchymal stromal cells (hMSCs) and 3 hMSCs after 72 hours (hr) of osteogenic differentiation, was used to screen for differentially expressed mRNAs. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of these mRNAs were conducted using Gene Set Enrichment Analysis (GSEA). Then, the miRanda website was employed to detect the binding sites of DHRS3. In vitro experiments, including RT-PCR and western blotting, were used to detect miR-233 and DHRS3 expression levels 7 and 14 days (d) after the induction of osteogenic differentiation using human bone marrow-derived mesenchymal stem cells (hBMSCs). The target relationship between miR-223 and DHRS3 was confirmed by a dual luciferase assay. ALP (alkaline phosphatase) staining, ARS (Alizarin Red S) staining and western blotting (Runx2, OPN, OCN) were used to detect the level of osteogenic differentiation after transfection with miR-223 mimics and DHRS3 cDNA. Results: In this study, 127 mRNAs differentially expressed during osteogenic differentiation were identified in GSE80614. GO term and KEGG pathway enrichment analyses found that the retinol metabolism pathway was activated during osteogenic differentiation and that DHRS3, which is involved in the pathway, was upregulated. During osteogenic differentiation in hBMSCs, miR-223 was gradually downregulated, while DHRS3 was upregulated. After 14 days of osteogenic differentiation, ALP and ARS staining assay results showed strong ALP activity and extracellular matrix calcification with the inhibition of miR-223 or the overexpression of DHRS3. Furthermore, the expression levels of Runx2, OPN, and OCN were upregulated with the knockdown of miR-223 or the overexpression of DHRS3, while the simultaneous transfection of a miR-223 agomir and DHRS3 cDNA resulted in no significant difference from the negative control (NC) group. Conclusion: The inhibition of miR-223 promotes the osteogenic differentiation of hBMSCs via the upregulation of DHRS3.

show abstract

Section: Introductionmentioning

confidence: 99%

MicroRNA-223 Suppresses Osteoblast Differentiation by Inhibiting DHRS3

Zhang

Liu

Zheng

et al. 2018

Cell Physiol Biochem

View full text Add to dashboard Cite

show abstract

“…Bone defects caused by traumas, congenital malformations or diseases cause enormous social and economic burdens, which seriously affect people's quality of life worldwide [1]. The main issue in the treatment and prevention of these diseases remains how to promote osteogenesis.…”

Section: Introductionmentioning

confidence: 99%

MicroRNA-10a Influences Osteoblast Differentiation and Angiogenesis by Regulating β-Catenin Expression

Zhang

Zhao

et al. 2015

Cell Physiol Biochem

View full text Add to dashboard Cite

Background/Aims: Elucidation of the molecular mechanisms governing osteoblast differentiation and angiogenesis are of great importance for improving the treatment of bone-related diseases. In this study, we examined the role of microRNA (miR)-10a in the differentiation of MC3T3-E1 cells and pro angiogenic activity of mouse umbilical vein endothelial cells (MUVECs). Methods: The murine pre-osteoblast cell line MC3T3-E1 and MUVECs were used in the experiment. After transfected with miR-10a mimics or inhibitors, with or without LiCl pretreatment, the miR-10a, ALP, Runx2, Osx, OC and Dlx5 expression were assessed by RT-PCR. MC3T3-E1 cells were cultured with BMP2 to differentiate into bone cells, osteogenic differentiation of MC3T3-E1 cells were detected by ALP and ARS staining. Cell viability were analyzed by MTT and the protein expression of β-catenin, LEF1, cyclinD1, MMP2, and VEGF were detected by Western blotting; VEGF and VE-cadherin release were assessed by ELISA, and the migration of MUVECs, as well as tube formation were also detected. Results: MiR-10a expression was obviously down-regulated during osteogenic differentiation. Overexpression of miR-10a inhibited osteogenic differentiation of MC3T3-E1 cells, effectively decreasing MUVECs proliferation, migration, VEGF expression, VE-cadherin concentrations, and tube formation in vitro, whereas miR-10a silence enhanced those processes. Further mechanism assays demonstrated that overexpression of miR-10a reduced the β-catenin at both protein and transcription level, while pretreatment with Wnt signaling activator Licl partially attenuated the suppression effects of miR-10a overexpression on osteoblast differentiation and angiogenesis. Conclusion: Our findings imply that miR-10a plays a suppressive role in osteoblast differentiation of MC3T3-E1 cells and pro angiogenic activity of MUVECs by regulating the β-catenin expression, representing a novel and potential therapeutic target for the treatment of bone regeneration-related diseases.

show abstract

“…Then the enzyme Drosha and its associated protein DGCR8 process pri-miRNA into a 70-nucleotide precursor miRNA (pre-miRNA) in nucleus [27,28]. An alternative pathway for pre-miRNA biogenesis in nucleus known as mirtrons has also been confirmed.…”

Section: Biogenesis Of Mirnamentioning

confidence: 94%